3.1. Generally Accepted Views
Some products are consistently contraindicated in pregnant women, both in official recommendations and by the analysed health portals. These include addictive substances such as cigarettes and alcohol [
3,
4]. In this respect, information on all medical portals is in agreement with recommendations stating that these products should be completely avoided during pregnancy due to their obvious and well-documented health risks.
Another area of agreement are foodborne pathogens. The danger of microbial contamination pertains as much to pregnancy, as it does to the rest of society, it is therefore necessary to choose food products with due care to minimise the risk of infection and avoid the associated negative health effects. Among the products most commonly advised against for this reason are raw milk and other dairy products, meat (especially deli meats), eggs, fish (e.g., sushi) and seafood, salads (especially deli salads), refrigerated pâté and meat spreads, sprouts, and soft cheeses (although in Poland cheeses are produced mostly from pasteurized milk). In general, health portals agree that raw/undercooked and/or unpasteurized products should not be consumed during pregnancy.
While caffeine has traditionally been a topic of disagreement as to its health-related benefits or harms, there is in fact a greater scientific consensus in the area than the controversy would suggest. Fortunately, the analysed portals reflect the consensus. The safety assessment of caffeine published by Health Canada in 2003 is one of the most often cited source in peer-reviewed literature [
5], recommending the dose not associated with adverse effects in healthy pregnant women, i.e., 300 mg/day. The same dose has been adopted in the WHO recommendations [
6]. The European Food Safety Authority issued a more conservative recommendation in 2021 which stated that regular consumption of up to 200 mg of caffeine a day by pregnant and breastfeeding women can be considered safe [
7]. Nine out of the ten analysed portals adhere to the findings of either of the aforementioned sources, with most of them recommending the lower limit. The only exception is Medycyna Praktyczna, which recommends that pregnant women should avoid coffee altogether. It should also be noted that products other than coffee, such as black tea or chocolate, are also rich in caffeine and their consumption may lead to an accidental increase of daily caffeine intake.
In addition to the accurate intake recommendations, the fact that the portals do not recognize coffee merely as a disposable stimulant, but rather as a valid part of diet must be seen as a positive. Still, more detailed information on those products that contain caffeine would provide a broader perspective on the topic and increase nutritional awareness among pregnant women, especially when considering that the unit of coffee consumption used by the portals is usually ‘a cup’. This may be unintentionally misleading unless a clear distinction between, e.g., espresso and back tea is made in terms of their caffeine content.
Adequate fluid intake is another key aspect of a pregnant woman’s diet. According to EFSA, the total water intake in pregnancy should be 2300 ml/day [
8]. However, data concerning the recommended water intake varies [
9] and the available information is limited [
10]. Similarly to the aforementioned situation, i.e., coffee not being the only product contributing to caffeine intake, it must be remembered that in the case of fluid intake in general, popular drinks such as coffee, tea, juices, drinks, and milk – as well as fruit and vegetables – also contribute to the overall fluid balance. This needs to be remembered in light of the fact that advice concerning fluid-rich products usually focuses on their other beneficial properties and thus the overall fluid intake may be in fact exceeded.
Fluid intake seems to be the most basic aspect of nutrition in general, and in pregnancy in particular. Yet, although “drink plenty of fluid” is indeed the advice consistently repeated on the analysed portals, fluid intake is not in fact subject to specific WHO recommendations. Granted, specific doses may not be as important in this case as a general emphasis on proper hydration; however, in the authors’ opinion, specific WHO norms could hardly be regarded as detrimental, offering a concrete point of reference. Fortunately, EFSA fills this gap. Generally speaking, fluid intake is agreed to be crucial during pregnancy, as reflected in the data available on the analysed health portals. The recommendations concerning fluid and caffeine intake in pregnancy are presented in
Table 1.
Most portals are also in agreement as to their advice against extreme (i.e., deficient, one-sided) diets in pregnancy. This is the correct approach as pregnant women are a special group in which the need for most nutrients is significantly increased. To ensure the proper development of the foetus, the diet should be as varied as possible and rich in all kinds of vitamins and minerals, which is impossible in the case of the popular extreme dieting regimens, e.g., keto or paleo.
Another area of general agreement throughout the analysed portals are those specific foods that universally described as excellent sources of nutrients. One such product are whole grains, presented as rich sources of proteins, carbohydrates, or iron, with the specific focus varying on different portals. Other widely recommended foods include legumes (e.g., beans or peas), cereal, rice, nuts, or pasta. It must be noted, though, that the analysed health portals are often inconsistent in their approach to data presentation. For instance, some of them focus on providing advice on the amounts, or portions, of various foods to be consumed during pregnancy. In contrast, others give examples of products to be consumed when mentioning a particular nutrient. Still other portals prioritize supplementation, as opposed to a balanced diet, whatever particular diet a woman decides to adhere to. In the latter case, most portals display a pronounced focus on precision, reflected in providing specific doses. A minor concern must be mentioned concerning USA-based portals – they tend to provide data in Imperial Units such as pounds or ounces, which is an obvious hindrance for non-American users.
3.2. Macronutrients
Due to the need to maintain maternal metabolism and tissue growth, and to support foetal growth and development, the demand for nutrients increases during pregnancy [
11]. Inadequate intake or deficiencies of key macro- and micronutrients can therefore have a significant impact on pregnancy outcomes and neonatal health.
It is a well-established fact that protein demand increases during pregnancy. Although all of the analysed health portals agree, the recommended amounts of protein intake are provided in two different manners – if at all. Some of the portals quote the total amount of protein to be consumed per day, expressed in grams/day, while others provide information on the recommended amount of protein intake, expressed in grams per kilogram of body weight / day. Given the substantial individual differences in body weight among pregnant women, it seems that the more adequate way to provide the recommended amount of dietary protein intake would be the latter. This would make it easier for pregnant women to estimate their individual protein needs.
Half of the portals, i.e., Medline Plus, Health.gov, John Hopkins, NHS, and WebMD, only report the need for an increased daily protein intake during pregnancy, without giving any specific data. Medycyna Praktyczna, 1000dni.pl, and Mayo Clinic, on the other hand, report the range of recommended protein intake for pregnant women, i.e., from 54 to 96 g/day. Only NCEZ and HealthLine give recommendations for protein intake in terms of g/kg of body weight. Still, there is a slight difference between the data presented on the two portals as HealthLine’s recommendation is 1.1 g/kg body weight, while NCEZ’s recommendation is 1.2 g/kg body weight.
Scientific recommendations in this area are also inconclusive. The recommendations on protein requirements in pregnant women issued in 2005 by the Institute of Medicine (IOM) state that the EAR (Estimated Average Requirement) in pregnancy is 0.66g/kg bw/day in the first trimester. In the second and third trimesters, protein intake increases by an average of 21 g/day, resulting in an EAR of 0.88 g/kg bw/day. In contrast, the RDA (Dietary Reference Intake) is 0.8 g/kg bw/day in the first trimester and 1.1 g/kg bw/day in the second and third trimesters [
12]. In 2001, EFSA identified protein needs of 1, 9, and 28 g/day in the respective trimesters of pregnancy [
13]. The latest recommendations, issued in 2019 by D-A-CH (the nutrition societies of Germany, Austria, and Switzerland), set the requirements for protein intake at 0.8, 0.9, and 1.0 g/kg bw/day during the first, second, and third trimesters, respectively [
14].
With regard to fat intake recommendations, there is no consensus among the portals. John Hopkins simply states that fats should be kept to a minimum. Health.gov recommends eating low-fat products, while the NHS recommends limiting fatty products. The WebMD recommends consuming fats at 30% or less of the daily requirement; the 1000dni.pl recommends consuming fats between 30-35% of the daily requirement; while the NCEZ gives recommendations in the form of recommended increases in the amount of fat, given in grams for a specific trimester, i.e., +8-14 g/day in the second trimester and +11-18 g/day in the third trimester. The other portals do not specify the recommended fat intake for pregnant women.
Official recommendations set by WHO do not specify the total fat intake in pregnancy. EFSA, on the other hand, indicates that fat supply during pregnancy may comprise 35% of the total energy intake [
15]. This data is also reflected in the information provided by WebMD and 1000dni.pl.
An important issue that needs to be addressed in the context of fats are omega-3 polyunsaturated fatty acids (PUFAs). In the context of the human body, the most important omega-3 PUFAs are those sourced from fatty fish, i.e., long-chain omega-3 (LCn3) acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and plants, i.e., alpha-linolenic acid (ALA) [
16]. Health portals give fatty fish, nuts, seeds, or avocado as sources of healthy fats, which is the correct advice.
On the other hand, the analysed portals only mention EPA and DHA acids, omitting the topic of ALA acids altogether even though they are also an omega-3 fatty acid. EPA and DHA acids are extremely important components in the context of pregnancy [
17,
18] and their only source in food are fatty fish and seafood. The John Hopkins portal lists nuts as a source of omega-3 acids, which contains a significant understatement, as nuts are a source of ALA acid only; they do not contain EPA or DHA acids.
Only the Polish portals provide the recommended intake of DHA. 1000dni.pl recommends consuming at least 200 mg of DHA per day, more if fish consumption is insufficient, and 1000 mg/day of DHA in case of increased risk of premature birth. Medycyna Praktyczna recommends consuming 600 mg/day from the 20th week of pregnancy and 1000 mg/day in case of increased risk of premature birth. On the other hand, NCEZ recommends consuming 200 mg/day of DHA and 1000 mg/day of DHA in case of increased risk of premature birth throughout the entire pregnancy.
In general, information concerning omega-3 acids presented by the analysed health portals largely lack consistence. As mentioned, only the Polish portals provide specific dosages, whereas the English-language portals only offer generic information on the sources of omega-3 acids, with example products differing between portals. Moreover, Mayo Clinic and – to some extent – Medline Plus recommend omega-3 supplementation only in case of deficiency, which is not strictly accurate. It is also worth noting that while the health portals make mention of fish oil, explicitly or implicitly, in relation to omega-3 supplementation, they fail to provide meaningful details, with recommendations ranging from inconclusive, through overly cautious, to very general, i.e., in the form of statements on the benefits of fish consumption.
Recommendations from 2007, developed through a collaboration between several scientific societies, state that fat consumption during pregnancy should align with recommendations for the general population. Moreover, pregnant women should aim to consume an additional 200 mg/day of DHA, e.g., in the form of oily sea fish once a week [
19]. Most recommendations for pregnant women relate to the consumption of specific types of fats, such as trans fats or omega-3 fatty acids; however, there is a lack of more comprehensive recommendations that would provide information regarding overall fat intake during pregnancy. These may be due to the fact that the fat requirement in pregnancy does not increase significantly and is similar to that of adults. However, clear recommendations would constitute a better reference for the development of recommendations for pregnant women, which would in turn facilitate women’s access to reliable information.
Other FAO recommendations from 2010 suggest consuming 300 mg/day of EPA+DHA, of which 200 mg/day should be DHA [
20]. On the other hand, EFSA recommendations from 2010 advise an additional 100-200 mg/day of DHA and over 250 mg/day of EPA+DHA [
21]. Additionally, the World Association of Perinatal Medicine recommends 200 mg/day of DHA [
19]. Recommendations also state that consuming long-lived predatory fish, which contain contaminants such as methylmercury and/or organic toxins, should be avoided [
11]. Consumption of plant-derived alpha-linolenic acid is not recommended because humans poorly convert the omega-3 fatty acid into EPA and are unable to convert EPA into DHA in sufficient amounts [
11].
In addition to PUFAs, evidence-based recommendations concerning saturated fatty acids and trans fatty acids are an important issue. Unfortunately, none of the analysed health portals referred to the recommended intake of saturated and trans fatty acids during pregnancy. Most drug societies recommend limiting the intake of saturated fatty acids to 10% [
22,
23,
24] and trans fatty acids to 1% of daily energy requirements or as low as possible [
15,
22,
24]. These recommendations apply to adults generally – there are no specific recommendations for pregnant women.
Although the analysed health portals pay considerable attention to fish and seafood – not only in relation to omega-3 acids – the advice they give is often both inconsistent and impractical. Due to their high nutritional value – especially in terms of macronutrients, particularly polyunsaturated fatty acids, including omega-3 acids – consumption of seafood is generally recommended. Considering this, the health portals generally recommend fish and seafood as products appropriate for pregnant women, if not consumed raw or undercooked, yet precise advice on which species it is safe or unsafe to consume varies. For example, the portals recommend avoiding products such as high-mercury seafood and fish, raw fish, or cold smoked fish, which is consistent with the scientific consensus, but some portals discourage the consumption of all smoked fish, which is an overgeneralization.
Mercury content is a problematic issue as far as the analysed portals are concerned. Nine out of ten (all except John Hopkins) advise against consuming high-mercury seafood and fish, yet only one (Mayo Clinic) proposes a useful heuristic, i.e., the bigger and older the fish, the more mercury it may contain. Such practical approach enables the consumer to actually distinguish between high- and low-mercury fish and seafood, which would otherwise remain a very unclear and impractical distinction. Moreover, two other portals (HealthLine and WebMD) provide examples of high-mercury fish, but none of high-mercury seafood. When low-mercury fish and seafood are described specifically, more examples are given of both, but despite the general consensus, i.e., a positive recommendation for their consumption, the details do not always align. For example, while WebMD classifies farmed salmon as a high-mercury fish, 1000dni.pl places it in the low-mercury category. Similarly, while 1000dni.pl recommends shrimp, NCEZ advises pregnant women to avoid it.
In terms of carbohydrates, the majority of the analysed portals do not provide precise information regarding the proportion of carbohydrates that would cover the needs of pregnant women. An important consideration in this context is that carbohydrates are always complementary to fats and proteins. It does not seem reasonable, however, to expect most women to be aware of this fact. For this reason, including information about this relationship on health portals would certainly prove beneficial and practical. Regarding food sources, the portals are rather consistent, recommending that the intake of simple sugars and highly processed products should be limited.
As far as recommendations issued by scientific societies are concerned, no specific guidelines regarding carbohydrate intake among pregnant women are given. However, in the case of recommendations for the entire adult population, according to the Nordic Nutrition Recommendations, carbohydrates (including energy obtained from dietary fibre) should comprise 50 to 60% of the total energy intake, while the intake of refined, added sugars should not exceed 10 E% [
23]. In addition, the Netherlands Health Council recommends an intake of 272 to 282 grams of carbohydrates per day, which is equivalent to approx. 40 E% [
25]. In contrast, the German-Austrian-Swiss recommendations (D-A-CH, 2008) specify the level of carbohydrate intake at no less than 50 E% [
22].
It would be useful to include information on the percentage of energy that should be provided by carbohydrates in the relevant recommendations, as exemplified by the recommendations quoted above. To make it easier for pregnant women to follow the advice and to understand the principles of healthy nutrition, such information should be included on health portals even if carbohydrates were to be obtained in the form of dietary supplements.
Another very important aspect regarding carbohydrates is dietary fibre. Unfortunately, none of the analysed health portal provides the recommended amounts of fibre to be consumed in pregnancy. There are also no official recommendations regarding dietary fibre intake for pregnant women. However, most scientific societies agree that the fibre content in the diet of adult women should be around 25-35 g/day [
12,
23,
24,
26]. More concerning is the lack of WHO norms for pregnant women concerning macronutrients, including carbohydrates and fibre, as these are provided only for the general population. Such omissions are reflected in the data available on the analysed health portals as their advice is often vague and sometimes inconsistent. In the case of fibre, any mention is largely absent from the portals. Recommendations concerning macronutrients in pregnancy are presented in
Table 2.
3.3. Supplementation: Microelements and Herbs
The concept of supplementation is closely connected with the overreaching aim of pregnant women to focus on their health and do whatever is necessary to make sure the baby will thrive. For this reason, using dietary supplements is seen as a desirable activity – one that doubtlessly leads to the improvement of wellbeing. This often results in the following overgeneralization: any supplementation is beneficial. This reasoning is obviously fallacious, and even more so in the case of pregnant women. While suboptimal micronutrient intake during pregnancy can lead to maternal nutrient deficiencies, associated with poorer pregnancy outcomes and adverse foetal outcomes, such as poor foetal growth, preterm birth, decreased infant survival, and increased risk of chronic diseases later in life [
27,
28,
29,
30], supplementation during pregnancy must be careful and based on actual recommendations.
The analysed health portals pay much attention to micronutrient supplementation, with varying levels of accuracy and consistency. Interestingly, almost none of the micronutrients is subject to stringent norms or recommendations, issued by WHO or other relevant organizations, with the notable exceptions of iron and calcium. The primary focus of research concerning micronutrient deficiencies during pregnancy is overwhelmingly on folate and vitamin D. Researchers corroborate this, also adding that deficiencies in iron, iodine, and zinc frequently escape adequate attention, despite their substantial repercussions on public health, while calcium, fluorine, selenium, and magnesium incur the most significant health-related expenses [
31]. However, scientific studies rectify this gap to a certain extent by providing some relevant data [
6,
31,
32], reflected in recommendations presented on some of the analysed portals.
Iron is a micronutrient essential for the process of tissue respiration, red blood cell formation, DNA synthesis, and regulation of the immune system function. Iron deficiency leads to anaemia, immune disorders, poor concentration, and cardiac arrhythmias. During pregnancy, anaemia increases the risk of premature labour and low birth weight [
33]. Calcium, on the other hand, is involved in neuromuscular conduction, blood clotting, and regulation of the heart and blood vessels. Calcium deficiency causes increased excitability of the body, tetany, blood clotting disorders, and may also lead to increased blood pressure [
34,
35]. As far as iron and calcium are concerned, it can be noted that the analysed health portals generally recommend doses that are slightly below the WHO norms. This could be explained by the fact that the recommendations emphasize the fact that supplementation is necessary mainly in instances of deficiencies. In this context, the conservative approach does seem relevant. Even those portals that do not provide exact doses for iron and calcium recommend their supplementation, with the exception of Medycyna Praktyczna, which advises against calcium supplementation.
In the cases of zinc and magnesium, the health portals offer three types of information. These include providing general advice to supplement the mineral or pointing out its increased demand during pregnancy (4 portals); the same advice but with exact doses given (2 portals); or no specific mention of the microelement in the context of pregnancy (4 portals). Magnesium is involved in neuromuscular conduction, thermoregulation, blood pressure regulation, and bone mineral metabolism. Its deficiency in pregnant women most often manifests as muscle cramps [
36]. All dosages given for magnesium on the analysed portals are consistent with recommendations – even if they do not match the recommended doses exactly. In the case of zinc, for which there are no clear recommendations, WebMD and Medline Plus do nevertheless give specifics, i.e., 11 mg/day (as part of prenatal supplements) and <34-40 mg/day, respectively. It is impossible, however to ascertain the sources of such data and thus its reliability. In general, it can be concluded that the advice found on health portals for zinc and magnesium is inconsistent, but fortunately, not harmful.
In the case of potassium, four portals view its supplementation as beneficial, another four do not mention it at all, while the rest advise against potassium in pregnancy supplementation beyond normal needs. As no official recommendations for the mineral exist, it is difficult to find such imprecise and inconsistent information reliable. The situation is similar with selenium. Some sources [
32] suggest that the dosage determined for the general population, i.e., 45-75 μg/day, applies to pregnant women as well, which is indeed reflected on HealthLine, WebMD, and Medline Plus, albeit with some level of tolerance. In addition, Medycyna Praktyczna mentions an increased demand of the element, in contrast with 1000dni.pl, which states otherwise. None of the other portals makes a mention of selenium in the context of pregnancy.
Iodine is an element essential for proper thyroid function. An insufficient supply of iodine in a pregnant woman’s diet can lead to the formation of thyroid goitre in the mother and mental underdevelopment in the child [
33,
37]. Out of the analysed microelements, iodine is the one which is described the most accurately by the analysed portals, the majority of which (six out of ten) provide recommendations falling closely within the recommended dose range of <220 µg/day. Three other portals recommend iodine supplementation without providing specific doses, while John Hopkins advises pregnant women not to supplement iodine.
While it is true that scientific sources fail to provide consistent data concerning the demand and/or supplementation needs of microelements during pregnancy – as reflected in the imprecise data available on the portals – more concerning are the omissions of certain microelements as part of the advice and the lack of clarity concerning the sources used for some of the specific data. On the other hand, it is worth emphasizing that the former problem may be due to a certain amount of caution on the part of the content creators, who try to avoid inaccuracies and prefer to err on the side of caution. Still, although the information concerning microelements provided by the analysed portals can hardly be regarded as potentially harmful, more openness in cases when scientific consensus is tentative or non-existent could be helpful.
A concerning aspect of pregnancy-related supplementation is advice concerning herbs. It is a common phenomenon, not only in the public perception but also among some medical practitioners, to perceive herbs as a safe alternative to pharmaceutical drugs [
1]. This is obviously fallacious reasoning, as the differing potencies of substances are not a consequence of their origin (i.e., a plant or a laboratory). This leads to pregnant women who wish to avoid medicines altogether to turn to a safer – in their estimation – alternative, i.e., herbs. Fortunately, the analysed health portals generally recommend caution when it comes to the consumption of herbs, yet some of them make the proviso that ‘safe’ herbs can be consumed, seemingly disregarding the fact that scientific evidence on the safety of herbs, especially concerning pregnancy, is extremely scarce. For example, Medycyna Praktyczna informs that herbal teas made from those herbs that are safe can be drunk during pregnancy. Yet, as concrete data on the safety of particular herbs may be unavailable, it is virtually impossible to apply this seemingly sound advice in practice.
One of the herbs that is commonly advised against is black cohosh (
Cimifuga racemose) used in supplements alleviating the symptoms of menopause [
38]. Indeed, the plant has been known for its labour-inducing properties, increasing the risk of miscarriage [
39]. A related plant, i.e., blue cohosh (
Caulophyllum thalictroides) has similar properties, in addition to a number of potentially lethal effects such as perinatal stroke, acute myocardial infarction, profound congestive heart failure and shock, and severe multi-organ hypoxic injury [
40]. Scientific data concerning other herbs is exceptionally limited, especially considering their potential practical applications. As far as certain popular herbs used in supplements and as spices are concerned – data concerning ginseng is conflicting [
41], while goldenseal and yarrow have been studied as part as a single pre-clinical trial, with yarrow proven to cause reduced foetal and placental mass [
42]. Mugwort (
Artemisia Vulgaris) [
43] has been the subject of a meta-analysis, yet the study’s methodology is not robust enough to consider the results reliable [
43]. In addition, gingko balboa has been found to induce perinatal bleeding due to its antithrombotic properties [
44]. Linseed oil, on the other hand, has not been found to possess harmful properties. Wormwood (
Artemisia absinthium) has not been tested in any scientific studies.
Interestingly, an herb often ingested as a measure to counteract nausea and vomiting, i.e., ginger, has indeed been found to be a safe and effective remedy in scientific studies [
45,
46]. A study performed by Boltman-Binkowski [
45] showed that pregnant mothers who refrained from consuming ginger did not exhibit a notably higher incidence of congenital abnormalities compared to those in the group who consumed ginger. Despite the scientific evidence and the popularity of ginger as a spice, only half of the analysed portals recommend its use, with a further one (Medline Plus) advising caution. In addition, WebMD provides a recommended dose, i.e., 350 mg four times a day. Such precise data, however, seems cherry-picked, as various studies tested differing doses, which are indeed roughly in the quoted area [
46], but no single dose has been indicated as the most accurate. In general, the example of ginger reflects the general lack of consistency of recommendations as far as herbs are concerned.
In general, herbs and herbal supplements need much more attention from health portals than they currently receive. Generally speaking, the haphazard information the portals provide seems to reflect the lack of research concerning herbal supplementation during pregnancy. Obviously, prospective studies of this kind would raise numerous ethical concerns, yet due to the fact that herbs themselves (e.g., spices) and herbal supplements are consumed widely and without much concern for their safety on the part of their users, pregnancy-related retrospective studies would provide the much-needed insight into the problem. As of the time of the writing of this article, pregnant women cannot expect to be given any useful advice concerning the herbs.
Overall, considering the huge number of herbs available as both dietary supplements and spices, the lack of evidence on their impact on pregnancy is troubling, with only two portals (HealthLine and Mayo Clinic) specifically mentioning lack of research in the area as the reason for vague or inexistent recommendations. Still, the fact that health portals adopt a mostly very cautious approach to the consumption of herbs during pregnancy must be seen as positive. Recommendations concerning the supplementation of micronutrients and herbs in pregnancy are presented in
Table 3.
3.4. Vitamins
In terms of vitamin supplementation, few are subject to WHO or other organizations’ standards. The only two officially recommended vitamins for supplementation are folic acid and vitamin D.
All the analysed portals’ recommendations follow the WHO guidelines [
6]. This means that in the case of folic acid, supplementation with 400 µg/day is consistently recommended, starting before pregnancy. However, portals such as HealthLine, WebMD, and MedlinePlus recommend that pregnant women should take up to 600 µg/day of folic acid. This does not follow from the WHO recommendations; however, EFSA does indeed state that the Adequate Intake (AI) of folic acid for pregnant women is 600 µg/day [
47]. The Polish portals, namely Medycyna Praktyczna, NCEZ, and 1000dni.pl, provide in their recommendations dosages that vary according to the risk of neural tube defects (NTDs). They recommend 800 µg/day of folic acid in the case of a moderate risk of neural tube defects and 4-5mg/day in the case of a high risk. This data is supported by a 1991 study, whose results showed that a dose of 4000 µg of supplemental folic acid significantly reduced the incidence of births with neural tube defects [
48].
Probably the most unexpected problem occurs in the case of B complex vitamins. In spite of the fact that the norms for B complex vitamins are widely-accepted and easy to find, no portals apart from WebMD use the data in their recommendations. The other portals only gave general recommendations to supplement them, without providing and specific data, i.e., dosages. In the case of foods rich in these vitamins, recommended for consumption in pregnancy, most health portals only specify a general pool of foods rich in B vitamins; only the aforementioned WebMD list foods rich in specific B vitamins and gives values for B vitamins similar to the EFSA recommendations [
47]. When taking into consideration the easy access to recommendations concerning the B vitamin complex, this situation is rather curious. In the case of English-language portals, this could be explained by their focus on ready-made OTC vitamin supplements available from pharmacies, i.e., a belief may be prevailing that the doses they contain are consistent with the recommended ones. However, all the analysed Polish-language portals also have the same issue, and as they do not focus on bulk supplementation, there must be additional causes of such an approach. Whatever the reason, the authors feel that such information should be updated with specific numbers based on the latest evidence and recommendations.
Choline is a nutrient essential for the proper functioning of the human body. Preclinical studies have shown that high choline intake during pregnancy or the perinatal period has neuroprotective effects on the foetus [
49,
50,
51]. Yet, most health portals only provide general recommendations for choline intake. No recommended doses are given. In contrast, the NHS portal does not mention choline at all in the context of the diet of pregnant women. The only portal that provides recommendations for choline requirements in pregnant women is HealthLine, with the recommended intake quoted as 450-930 mg/day, compared to the 480 mg/day recommended by EFSA [
47]. Its extra-diet supplementation is not advised. The dietary sources of choline recommended by the different health portals are consistent with each other.
Vitamin C is a nutrient that is widely distributed in food. Although its demand during pregnancy does increase, up to 105 mg/day [
47], additional supplementation is not recommended. Yet, only two health portals, i.e., Medline Plus and 1000dni.pl, mention this fact. Another portal, WebMD, states that the demand for vitamin C is 80-85 mg/day for pregnant women, which agrees with the recommendations issued by EFSA concerning the level of Vitamin C in the diet that meets the daily requirements of half of the people in a typical healthy population, i.e., the average requirement (AR).
Vitamin A intake is a crucial issue as far as dangers in pregnancy are concerned. Health portals should mention the dangers of excessive vitamin A consumption and its effects on the development of foetal defects more frequently and unambiguously. The requirement has been set by EFSA at 700 µg RE/day [
47], with additional supplementation not recommended except in areas of widespread vitamin A deficiency [
6]. Only the WebMD portal provides accurate recommendations for vitamin A intake during pregnancy, consistent with the EFSA guidelines. Importantly, it also includes information that vitamin A supplementation is not recommended for pregnant women, as does HealthLine. NCEZ and Medline Plus also warn against excessive vitamin A intake, mentioning that it can cause foetal defects, as confirmed both by WHO and in scientific studies [
52,
53,
54]. Other portals provide only general recommendations, without specific data. However, a list of specific foods rich in vitamin A, to be avoided or at least consumed in moderation, would be a very beneficial piece of information for pregnant women.
Vitamin D is one of the two vitamins widely recommended for supplementation during pregnancy. Compared to the clarity of advice in the case of folic acid, the situation with vitamin D is more complicated. The WHO recommends supplementation only in cases of confirmed deficiency, while the requirement set by EFSA is 600 IU/day (15 μg/day). Furthermore, the WHO recommends vitamin D supplementation for pregnant women at 200 IU/day (5 μg/day) in cases of vitamin D insufficiency [
6]. Most portals, however, recommend vitamin D supplementation at 600 IU/day. NHS recommends vitamin D supplementation of 400 IU/d from September to March, due to the reduced solar radiation during these months, which is associated with reduced vitamin D synthesis. The Polish portals, i.e., 1000dni.pl, Medycyna Praktyczna, and NCEZ, recommend vitamin D supplementation at much higher doses of 1500-2000 IU/day, with the dose increased to 4000 IU/day in cases of obesity. Although much different from the international recommendations, the data provided by the Polish portals is in fact consistent with the recommendations of the Polish Society of Gynecologists and Obstetricians [
55]. This wide discrepancy in recommendations between international and Polish bodies is rather puzzling and it would be interesting to know the reasons, as they are unclear.
According to the WHO and EFSA, the requirement for vitamin E during pregnancy is 11 mg/day [
6,
47]. Only WebMD indicates the need for this ingredient, yet the recommended amount differs slightly from the official recommendations of 13 mg/day. Only three portals, i.e., HealthLine, Medline Plus, and 1000dni.pl, report that regular vitamin E supplementation is not recommended. The other portals only give general or vague recommendations.
In the case of vitamin K, the requirement for pregnant women set by EFSA is 70 μg/day [
47], i.e., the same as for the general adult population. As for the analysed health portals, the information they provide on vitamin K is very general. WebMD, MayoClinic, and JohnHopkins report that regular vitamin K supplementation is not recommended during pregnancy, while the others make very general recommendations or do not mention vitamin K in the context of pregnancy at all.
Due to the relatively large focus of the analysed portals on OTC multivitamin supplements, the authors treated them a separate issue. Although the WHO only recommends multivitamin supplementation for pregnant women in middle-income countries [
56], all English-language portals recommend supplementation with OTC multivitamin preparations. In contrast, two Polish portals, i.e., 1000dni.pl and NCEZ, advise against supplementation with such preparations, while Medycyna Praktyczna has no clear recommendations on this issue. In general, it can be concluded that this issue has more in common with the easy availability of pre-prepared supplements in pharmacies than with their actual contents and their consistency with recommendations, with the analysed portals acting on the principle that officially approved products must be relatively well-prepared. This heuristic does not seem unreasonable, yet the authors feel that such ready-made solutions should be approached with a certain amount of caution, especially if they are not classified as medicinal products. Recommendations concerning the supplementation of vitamins in pregnancy are presented in
Table 4. The data concerning multivitamin supplements, vitamins D and A, and folic acid concern the supplementation of these nutrients; in all the other cases the data concerns demand.